Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 fatty acids in MDD and Bipolar Disorder
NCT05529576Phase 4Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Aug 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of omega-3 fatty acid in major depressive disorder (MDD), bipolar disorder (BD), sponsored by Shanghai Mental Health Center. Status: unknown.
02
Drugs
omega-3 fatty acid
03
Conditions
major depressive disorder (MDD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT05529576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05529576.